Immune Thrombocytopenia
We recommend
How do patients perceive the treatment of ITP with romiplostim?
Romiplostim, along with eltrombopag and avatrombopag, belongs to the group of thrombopoietin receptor agonists (TPO-RA) used in the second line of treatment for immune thrombocytopenia (ITP). Its efficacy and safety are confirmed by numerous studies, but how do patients perceive its use and to what extent does it improve their quality of life? This was the focus of a review article by authors from the American Baylor College of Medicine.
Central European Expert Consensus on the Treatment of ITP in Adult Patients
In a recently published consensus, experts from Central Europe evaluate the current treatment…
ICIS Report: Potential of TPO-RA as Early Immunomodulatory Treatment of Immune Thrombocytopenia
The report from the meeting of the Intercontinental Cooperative ITP Study Group (ICIS) in 2022 in…
Articles on this topic
Risk of Thromboembolism in ITP
Among other possible comorbidities in patients with ITP, thromboembolism represents one of the…
Self-Administration of Romiplostim in Chronic Immune Thrombocytopenia: Analysis of 3 Studies
A post hoc analysis of 3 clinical studies showed that in adult patients with chronic immune…
Efficacy of Romiplostim in Children with Persistent or Chronic ITP
The effect of the thrombopoietin receptor agonist romiplostim in adult patients with immune…
COVID-19 and Immune Thrombocytopenic Purpura − Spanish Experience Suggests Surprising Connections
In a retrospective study examining the impact of COVID-19 on immune thrombocytopenic purpura,…
Idiopathic Thrombocytopenic Purpura with SARS-CoV-2 Infection
To date, 45 cases of idiopathic (autoimmune) thrombocytopenic purpura (ITP) in individuals…
Sustained Remission of ITP with Thrombopoietin Receptor Agonists Treatment
Thrombopoietin receptor agonists (TPO-RAs) are highly effective drugs administered in chronic…
Study PLATON: romiplostim in patients with ITP in real clinical practice
Recently, the results of the PLATON study with romiplostim, which was conducted in Central and…
Pediatric Immune Thrombocytopenia Does Not Overlap with Adult ITP
Immune thrombocytopenia (ITP) is a highly heterogeneous disease characterized by various…
Recommendations for the diagnosis of ITP in adults and children according to ASH guidelines
The American Society of Hematology (ASH) guidelines from 2019 highlighted several important…
Current ASH Guidelines on ITP Management 2019 – Recommendations for Newly Diagnosed ITP in Children
At the end of 2019, the American Society of Hematology (ASH) published current guidelines for…
Subscribe
Most read on this topic
Journal on this topic
Related topic
Most read on this topic
- COVID-19 and Immune Thrombocytopenic Purpura − Spanish Experience Suggests Surprising Connections
- Idiopathic Thrombocytopenic Purpura with SARS-CoV-2 Infection
- Thrombocytopenia Following mRNA Vaccination Against SARS-CoV-2
- Fatigue as a Significant Symptom of Immune Thrombocytopenia from the Patients' Perspective
- Summary of Recommendations for the Treatment of Immune Thrombocytopenia in Pregnancy
- Current ASH Guidelines on ITP Management 2019 – Recommendations for Newly Diagnosed ITP in Children
Journal on this topic
Related topic